Industry
Biotech startups that just raised
We track 11 recently funded Biotech startups. 1 of their roles are open right now.
11 companies1 open role
- LifeMine Therapeutics →● 1 role
BiotechWatertown, Massachusetts$182M raisedAug 8, 2026
LifeMine Therapeutics is a drug discovery company developing therapies for transplantation and immunology.
BiotechGothenburg, Sweden$2.3M raisedAug 13, 2026
Millow produces mycelium-based protein ingredients from Swedish oats through solid-state fermentation for foodservice and retail companies.
BiotechHamburg, Germany$0 raisedAug 11, 2026
AquaNab develops nanoantibody-based precision immunotherapies administered through feed to prevent and treat diseases in aquaculture.
BiotechLuxembourg$1.2M raisedAug 11, 2026
Exobiosphere develops orbital high-throughput screening and drug-discovery platforms for automated biomedical experiments in microgravity.
BiotechGlasgow, United Kingdom$46M raisedAug 7, 2026
Mironid is a biopharmaceutical company developing treatments for rare genetic and degenerative kidney diseases, including autosomal dominant polycystic kidney disease.
BiotechOxford, UK$28M raisedJul 24, 2026
Moa Technology is an agricultural biotechnology company developing synthetic and biological herbicides to combat herbicide-resistant weeds.
BiotechLyon, France$12.6M raisedJul 22, 2026
Brenus Pharma develops off-the-shelf immuno-oncology therapies designed to generate immune responses against hard-to-treat solid tumors.
BiotechZürich, Switzerland$2.8M raisedJul 22, 2026
Immitra Bio develops scalable in-vivo gene-editing therapies using mutation-agnostic gene-editing technology and a digital target-identification platform.
BiotechBelgium$3.2M raisedJul 17, 2026
Sightera Biosciences uses generative AI and patient-derived biological data to develop small-molecule therapies for oncology and fibrosis.
BiotechItaly$2.7M raisedJul 15, 2026
Nous develops science-backed botanical functional ingredients for the food, beverage, and nutraceutical industries, including its flagship energy ingredient Koncentra.
Biotechnull$200M raisedJul 14, 2026
An unnamed startup being launched by OpenAI researcher Miles Wang to develop AI models for drug discovery.